Eli Lilly and - LLY Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
News Sentiment
About
FAQ

Consensus Rating: Buy
Consensus Price Target: $384.11
Forecasted Upside: 12.81%
Number of Analysts: 13
Breakdown:
0 Sell Ratings
2 Hold Ratings
11 Buy Ratings
0 Strong Buy Ratings

^$340.50 As of 01/30/2023 01:00 AM ET

▼ -1.6 (-0.47%)

1 month | 3 months | 12 months

Get New Eli Lilly and Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for LLY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for LLY

^$384.11

▲ +12.81% Upside Potential

This price target is based on 13 analysts offering 12 month price targets for Eli Lilly and in the last 3 months. The average price target is $384.11, with a high forecast of $440.00 and a low forecast of $286.00. The average price target represents a 12.81% upside from the last price of $340.50.

Current Consensus is Buy

The current consensus among 13 contributing investment analysts is to buy stock in Eli Lilly and. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
11 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

8/8/2021

0 strong buy ratings
13 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

11/6/2021

0 strong buy ratings
13 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

2/4/2022

0 strong buy ratings
14 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

5/5/2022

0 strong buy ratings
15 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

8/3/2022

0 strong buy ratings
12 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

11/1/2022

0 strong buy ratings
12 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

12/31/2022

0 strong buy ratings
11 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

1/30/2023

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
1/3/2023	Barclays	Boost Target	Overweight	$395.00 ➝ $400.00	Low
12/16/2022	SVB Leerink	Boost Target	Outperform	$384.00 ➝ $410.00	Low
12/15/2022	UBS Group	Lower Target	Buy	$428.00 ➝ $420.00	Low
12/14/2022	Morgan Stanley	Lower Target	Overweight	$446.00 ➝ $440.00	Low
12/14/2022	JPMorgan Chase & Co.	Boost Target		$380.00 ➝ $400.00	Low
12/9/2022	UBS Group	Boost Target		$407.00 ➝ $428.00	Low
12/8/2022	Wells Fargo & Company	Boost Target	Equal Weight	$365.00 ➝ $375.00	Low
12/7/2022	Guggenheim	Boost Target	Buy	$399.00 ➝ $401.00	Low
12/6/2022	Credit Suisse Group	Boost Target	Outperform	$395.00 ➝ $400.00	Low
12/6/2022	Morgan Stanley	Boost Target	Overweight	$436.00 ➝ $446.00	Low
12/5/2022	Cowen	Boost Target	Outperform	$390.00 ➝ $430.00	Low
12/5/2022	Cowen	Boost Target		$390.00 ➝ $430.00	Low
11/22/2022	Berenberg Bank	Boost Target	Buy	$345.00 ➝ $375.00	Low
11/17/2022	Credit Suisse Group	Initiated Coverage	Outperform	$395.00	Low
11/17/2022	Morgan Stanley	Lower Target	Overweight	$441.00 ➝ $436.00	Low
11/15/2022	Truist Financial	Boost Target		$400.00 ➝ $421.00	Low
11/8/2022	The Goldman Sachs Group	Boost Target	Neutral	$281.00 ➝ $313.00	Low
11/2/2022	SVB Leerink	Boost Target	Outperform	$341.00 ➝ $384.00	Low
11/2/2022	Morgan Stanley	Boost Target	Overweight	$408.00 ➝ $441.00	Low
11/2/2022	Wells Fargo & Company	Boost Target	Equal Weight	$305.00 ➝ $365.00	Low
11/2/2022	Barclays	Boost Target	Overweight	$355.00 ➝ $395.00	Low
10/12/2022	Morgan Stanley	Lower Target	Overweight	$412.00 ➝ $408.00	Low
9/30/2022	Argus	Boost Target		$315.00 ➝ $360.00	Low
9/22/2022	UBS Group	Upgrade	Neutral ➝ Buy	$335.00 ➝ $363.00	Low
9/7/2022	Morgan Stanley	Boost Target	Overweight	$395.00 ➝ $412.00	Low
9/6/2022	BMO Capital Markets	Boost Target	Outperform	$369.00 ➝ $396.00	Low
8/25/2022	Citigroup	Boost Target		$285.00 ➝ $370.00	Low
7/27/2022	UBS Group	Boost Target	Outperform	$335.00	Low
7/8/2022	Morgan Stanley	Boost Target	Overweight	$369.00 ➝ $395.00	N/A
7/7/2022	Barclays	Boost Target	Overweight	$333.00 ➝ $355.00	N/A
6/1/2022	JPMorgan Chase & Co.	Boost Target		$340.00 ➝ $355.00	Low
5/23/2022	SVB Leerink	Initiated Coverage	Outperform	$341.00	Low
5/2/2022	Mizuho	Boost Target		$315.00 ➝ $356.00	Low
4/29/2022	Morgan Stanley	Boost Target		$364.00 ➝ $369.00	High
4/29/2022	Wells Fargo & Company	Boost Target		$280.00 ➝ $305.00	Medium
4/12/2022	The Goldman Sachs Group	Boost Target	Neutral	$234.00 ➝ $264.00	Low
4/6/2022	Morgan Stanley	Boost Target	Overweight	$265.00 ➝ $364.00	High
3/17/2022	Bank of America	Boost Target		$300.00 ➝ $315.00	Medium
3/10/2022	Daiwa Capital Markets	Initiated Coverage	Outperform	$286.00	Medium
2/4/2022	Mizuho	Lower Target	Buy	$302.00 ➝ $293.00	High
2/4/2022	Morgan Stanley	Lower Target	Overweight	$272.00 ➝ $265.00	Medium
1/24/2022	Morgan Stanley	Lower Target	Overweight	$275.00 ➝ $272.00	Low
1/21/2022	DZ Bank	Upgrade	Hold ➝ Buy	$291.00	Medium
1/5/2022	Mizuho	Boost Target		$272.00 ➝ $302.00	High
1/4/2022	Wells Fargo & Company	Boost Target	Equal Weight	$270.00 ➝ $280.00	Low
1/3/2022	Sanford C. Bernstein	Boost Target	Market Perform	$250.00 ➝ $300.00	High
12/20/2021	Berenberg Bank	Boost Target	Buy	$270.00 ➝ $305.00	High
12/20/2021	Barclays	Boost Target	Overweight	$280.00 ➝ $325.00	High
12/17/2021	The Goldman Sachs Group	Initiated Coverage	Neutral	$236.00	High
12/16/2021	Mizuho	Initiated Coverage	Buy	$272.00	Low
12/16/2021	BMO Capital Markets	Boost Target	Outperform	$311.00 ➝ $320.00	Low
12/16/2021	Bank of America	Boost Target	Buy	$285.00 ➝ $300.00	Low
12/16/2021	JPMorgan Chase & Co.	Reiterated Rating	Buy		Low
12/8/2021	Wells Fargo & Company	Initiated Coverage	Equal Weight	$270.00	Low
11/24/2021	Truist Financial	Boost Target	Buy	$262.00 ➝ $301.00	Low
11/18/2021	BMO Capital Markets	Initiated Coverage	Outperform	$311.00	Medium
10/27/2021	Mizuho	Lower Target	Buy	$279.00 ➝ $272.00	Low
10/11/2021	Berenberg Bank	Upgrade	Hold ➝ Buy	$240.00 ➝ $270.00	Low
9/29/2021	Citigroup	Upgrade	Neutral ➝ Buy	$210.00 ➝ $265.00	High
9/24/2021	JPMorgan Chase & Co.	Reiterated Rating	Buy	$300.00	Low
8/30/2021	Cowen	Boost Target	Outperform	$250.00 ➝ $300.00	Low
8/9/2021	Argus	Boost Target	Buy	$225.00 ➝ $300.00	Medium
8/5/2021	DZ Bank	Upgrade	Hold ➝ Buy	$288.00	Low
8/4/2021	JPMorgan Chase & Co.	Boost Target	Top Pick ➝ Overweight	$270.00 ➝ $300.00	Medium
8/4/2021	Morgan Stanley	Boost Target	Overweight	$207.00 ➝ $275.00	High
8/4/2021	Mizuho	Boost Target	Buy	$250.00 ➝ $279.00	High
7/27/2021	Truist Financial	Initiated Coverage	Buy	$262.00	Low
7/7/2021	Mizuho	Reiterated Rating	Buy	$250.00	Low
7/6/2021	Barclays	Boost Target	Overweight	$227.00 ➝ $250.00	Low
7/2/2021	Truist Financial	Boost Target	Buy ➝ Buy	$225.00 ➝ $262.00	Low
6/24/2021	Cantor Fitzgerald	Boost Target	Positive ➝ Overweight	$245.00 ➝ $300.00	High
6/24/2021	Cowen	Boost Target	Positive ➝ Outperform	$235.00 ➝ $250.00	High
6/15/2021	JPMorgan Chase & Co.	Boost Target	Overweight	$240.00 ➝ $260.00	Low
6/14/2021	The Goldman Sachs Group	Boost Target	Positive ➝ Conviction-Buy	$252.00 ➝ $270.00	Low
6/8/2021	Truist Financial	Reiterated Rating	Buy	$225.00	Medium
4/28/2021	Morgan Stanley	Lower Target	Overweight	$217.00 ➝ $207.00	Medium
4/28/2021	Mizuho	Lower Target	Buy	$228.00 ➝ $216.00	Medium
4/28/2021	Barclays	Lower Target	Overweight	$232.00 ➝ $227.00	Medium
3/15/2021	Truist Financial	Boost Target	Buy	$215.00 ➝ $225.00	High
2/12/2021	Cowen	Boost Target	Outperform	$195.00 ➝ $235.00	Low
2/4/2021	Morgan Stanley	Boost Target	Overweight	$190.00 ➝ $217.00	Medium
2/1/2021	Truist Financial	Boost Target		$200.00 ➝ $215.00	Low
2/1/2021	Mizuho	Boost Target	Buy	$222.00 ➝ $228.00	Low
2/1/2021	Barclays	Boost Target	Overweight	$190.00 ➝ $232.00	Low
1/22/2021	Bank of America	Boost Target	Buy	$195.00 ➝ $225.00	Medium
1/19/2021	Mizuho	Upgrade	Neutral ➝ Buy	$164.00 ➝ $222.00	N/A
1/12/2021	Truist Financial	Boost Target		$182.00 ➝ $200.00	Medium
12/16/2020	Mizuho	Boost Target	Neutral	$156.00 ➝ $164.00	High
12/10/2020	Wolfe Research	Upgrade	Peer Perform ➝ Outperform	$147.00 ➝ $183.00	Medium
11/17/2020	Mizuho	Lower Target	Neutral	$164.00 ➝ $156.00	Low
11/10/2020	Sanford C. Bernstein	Initiated Coverage	Market Perform	$150.00	Low
10/28/2020	Morgan Stanley	Lower Target	Overweight	$176.00 ➝ $170.00	Low
10/23/2020	Truist Financial	Initiated Coverage	Buy	$180.00	Medium
10/16/2020	JPMorgan Chase & Co.	Boost Target	Overweight	$190.00 ➝ $200.00	Low
9/29/2020	Berenberg Bank	Initiated Coverage	Hold	$144.00	Medium
9/3/2020	Morgan Stanley	Upgrade	Equal Weight ➝ Overweight	$149.55 ➝ $176.00	High
8/14/2020	Morgan Stanley	Boost Target	Equal Weight	$148.00 ➝ $157.00	Low
6/29/2020	Mizuho	Boost Target	Neutral	$155.00 ➝ $164.00	Low
6/19/2020	Bank of America	Reiterated Rating	Buy	$180.00	Low
6/17/2020	JPMorgan Chase & Co.	Boost Target	Overweight	$175.00 ➝ $190.00	Low
6/16/2020	Guggenheim	Upgrade	Neutral ➝ Buy	$182.00	High
4/24/2020	Mizuho	Boost Target	Buy	$148.00 ➝ $155.00	Low
4/24/2020	Cfra	Boost Target	Hold	$146.00 ➝ $167.00	Low
4/24/2020	Cantor Fitzgerald	Boost Target	Overweight	$156.00 ➝ $185.00	Low
4/20/2020	UBS Group	Downgrade	Buy ➝ Neutral	$157.00 ➝ $158.00	High
4/19/2020	Morgan Stanley	Downgrade	Overweight ➝ Equal Weight		Low
4/15/2020	Cowen	Boost Target	Outperform	$145.00 ➝ $160.00	Medium
4/9/2020	Morgan Stanley	Downgrade	Overweight ➝ Equal Weight	$148.00	Low
4/2/2020	Mizuho	Reiterated Rating	Hold	$148.00	Medium
4/2/2020	Morgan Stanley	Lower Target	Overweight ➝ Equal Weight	$150.00 ➝ $148.00	High
3/11/2020	The Goldman Sachs Group	Upgrade	Buy ➝ Conviction-Buy	$168.00	Medium
2/27/2020	Barclays	Initiated Coverage	Overweight		High
2/18/2020	Cantor Fitzgerald	Reiterated Rating	Buy	$156.00	Low
2/5/2020	Mizuho	Initiated Coverage	Neutral	$148.00	Low
2/3/2020	Cantor Fitzgerald	Reiterated Rating	Buy	$156.00	Medium
12/30/2019	Argus	Boost Target	Buy	$145.00 ➝ $165.00	Low
12/18/2019	JPMorgan Chase & Co.	Boost Target	Overweight	$140.00 ➝ $150.00	High
12/18/2019	Morgan Stanley	Upgrade	Equal Weight ➝ Overweight	$116.00 ➝ $150.00	High
12/2/2019	Cantor Fitzgerald	Reiterated Rating	Buy	$143.00	Low
10/17/2019	UBS Group	Lower Target	Buy	$134.00 ➝ $133.00	Low
10/16/2019	Bank of America	Initiated Coverage	Buy	$133.00	Low
9/10/2019	Bank of America	Set Target	Neutral	$118.00 ➝ $120.00	High
5/28/2019	The Goldman Sachs Group	Initiated Coverage	Buy ➝ Buy	$135.00	Low
5/1/2019	BMO Capital Markets	Boost Target	Outperform ➝ Outperform	$130.00 ➝ $133.00	Low
4/30/2019	Cantor Fitzgerald	Reiterated Rating	Buy	$143.00	Medium
4/23/2019	Edward Jones	Upgrade	Hold ➝ Buy	$117.49	Low
4/22/2019	BMO Capital Markets	Lower Target	Outperform	$130.00	Medium
4/14/2019	Barclays	Reiterated Rating	Buy	$140.00	Low
4/11/2019	Guggenheim	Downgrade	Buy ➝ Neutral	$125.84	Low
3/22/2019	Credit Suisse Group	Set Target	Hold	$121.00	Low
3/21/2019	Bank of America	Set Target	Hold	$129.00	Low
3/20/2019	UBS Group	Initiated Coverage	Buy	$140.00 ➝ $74.51	Low
3/12/2019	JPMorgan Chase & Co.	Initiated Coverage	Overweight ➝ Overweight	$140.00	Low
2/26/2019	Citigroup	Set Target	Hold	$124.00	Medium
2/8/2019	UBS Group	Lower Target	Average	$107.53 ➝ $100.00	Low
2/4/2019	Cantor Fitzgerald	Reiterated Rating	Buy		Low
1/23/2019	UBS Group	Initiated Coverage	Buy ➝ Buy	$131.00	Low
1/20/2019	Barclays	Reiterated Rating	Buy	$130.00	Low
12/27/2018	Argus	Reiterated Rating	Buy		Medium
12/24/2018	BMO Capital Markets	Boost Target	Outperform	$124.00 ➝ $132.00	Low
12/20/2018	Morgan Stanley	Set Target	Hold	$116.00	High
12/19/2018	BMO Capital Markets	Reiterated Rating	Buy		Low
12/2/2018	Citigroup	Downgrade	Buy ➝ Neutral	$113.00	Low
11/26/2018	Citigroup	Downgrade	Buy ➝ Neutral	$115.00	Low
11/7/2018	Societe Generale	Set Target	Hold	$106.00	High
10/31/2018	Credit Suisse Group	Upgrade	Underperform ➝ Neutral		Medium
10/23/2018	Wolfe Research	Initiated Coverage	Market Perform	$119.00	Low
10/17/2018	Cantor Fitzgerald	Reiterated Rating	Buy	$128.00	Medium
10/12/2018	Barclays	Boost Target	Overweight	$112.00 ➝ $120.00	Low
10/8/2018	Guggenheim	Initiated Coverage	Buy ➝ Buy		Low
10/5/2018	JPMorgan Chase & Co.	Set Target	Buy	$123.00	Low
10/4/2018	BMO Capital Markets	Upgrade	Market Perform ➝ Outperform	$107.00 ➝ $130.00	High
10/3/2018	BMO Capital Markets	Boost Target	Market Perform ➝ Market Perform	$90.00 ➝ $107.00	Medium
10/1/2018	SunTrust Banks	Boost Target	Buy ➝ Buy	$105.00 ➝ $123.00	Low
9/27/2018	Cantor Fitzgerald	Set Target	Buy	$110.00	Low
9/26/2018	JPMorgan Chase & Co.	Set Target	Not Rated ➝ Overweight	$117.00	Low
9/18/2018	Barclays	Reiterated Rating	Overweight	$107.00 ➝ $112.00	Low
9/17/2018	Cantor Fitzgerald	Set Target	Buy	$110.00	Low
9/7/2018	Barclays	Boost Target	Overweight ➝ Overweight	$98.00 ➝ $107.00	Medium
7/31/2018	Morgan Stanley	Boost Target	Equal Weight ➝ Equal Weight	$93.00 ➝ $102.00	Low
7/31/2018	SunTrust Banks	Reiterated Rating	Buy	$105.00	Low
7/25/2018	Bank of America	Boost Target	Neutral ➝ Neutral	$90.00 ➝ $94.00	Medium
7/25/2018	Credit Suisse Group	Boost Target	Underperform ➝ Underperform	$84.00 ➝ $86.00	High
7/25/2018	BMO Capital Markets	Boost Target	Market Perform ➝ Market Perform	$80.00 ➝ $90.00	High
7/25/2018	Cantor Fitzgerald	Boost Target	Overweight ➝ Overweight	$100.00 ➝ $110.00	High
7/25/2018	Berenberg Bank	Downgrade	Buy ➝ Hold	$99.00	High
7/25/2018	The Goldman Sachs Group	Set Target	Neutral	$100.00	High
7/24/2018	Cowen	Set Target	Buy	$105.00	High
7/24/2018	Cantor Fitzgerald	Set Target	Buy	$100.00	High
7/19/2018	BMO Capital Markets	Boost Target	Market Perform ➝ $89.43	$78.00 ➝ $80.00	Medium
7/17/2018	Cantor Fitzgerald	Set Target	Buy	$100.00	Low
7/17/2018	Bank of America	Boost Target	Neutral ➝ Neutral	$86.00 ➝ $90.00	Low
7/15/2018	Jefferies Financial Group	Set Target	Buy	$100.00	Low
7/13/2018	Credit Suisse Group	Set Target	Hold	$84.00	Low
7/9/2018	Cantor Fitzgerald	Set Target	Buy	$100.00	Low
6/22/2018	DZ Bank	Reiterated Rating	Buy ➝ Hold		Low
6/21/2018	Credit Suisse Group	Boost Target	Underperform ➝ Underperform	$82.00 ➝ $84.00	Low
6/11/2018	JPMorgan Chase & Co.	Set Target	Buy	$100.00	Low
6/7/2018	Cantor Fitzgerald	Initiated Coverage	Overweight	$100.00	Low
5/22/2018	Barclays	Set Target	Buy	$98.00	Low
5/15/2018	Credit Suisse Group	Set Target	Hold	$82.00	Low
5/10/2018	BMO Capital Markets	Reiterated Rating	Hold	$78.00	Low
4/25/2018	BMO Capital Markets	Lower Target	Market Perform ➝ Market Perform	$79.00 ➝ $78.00	Medium
4/24/2018	BMO Capital Markets	Reiterated Rating	Hold	$79.00	Medium
4/22/2018	Credit Suisse Group	Set Target	Hold	$80.00	Medium
4/18/2018	HC Wainwright	Reiterated Rating	Buy		Low
4/13/2018	BMO Capital Markets	Upgrade	Underperform ➝ Market Perform	$74.00 ➝ $79.00	Low
4/13/2018	Jefferies Financial Group	Set Target	Buy	$90.00	Low
4/4/2018	BMO Capital Markets	Reiterated Rating	Sell	$74.00	Medium
3/23/2018	Jefferies Financial Group	Reiterated Rating	Buy	$91.00	Medium
2/26/2018	Jefferies Financial Group	Set Target	Buy	$93.00	Low
2/26/2018	JPMorgan Chase & Co.	Set Target	Buy	$105.00	Medium
2/2/2018	Credit Suisse Group	Reiterated Rating	Hold	$80.00	Low
2/1/2018	Bank of America	Lower Target	Neutral ➝ Neutral	$88.00 ➝ $86.00	Low
2/1/2018	BMO Capital Markets	Boost Target	Underperform ➝ Underperform	$73.00 ➝ $74.00	Low

(Data available from 1/31/2018 forward)

News Sentiment Rating

0.52 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

19 very positive mentions
46 positive mentions
7 negative mentions
12 very negative mentions

Mentions as of

7/4/2022

7 very positive mentions
21 positive mentions
2 negative mentions
0 very negative mentions

Mentions as of

8/3/2022

10 very positive mentions
76 positive mentions
12 negative mentions
9 very negative mentions

Mentions as of

9/2/2022

21 very positive mentions
41 positive mentions
4 negative mentions
4 very negative mentions

Mentions as of

10/2/2022

24 very positive mentions
48 positive mentions
9 negative mentions
2 very negative mentions

Mentions as of

11/1/2022

30 very positive mentions
87 positive mentions
13 negative mentions
16 very negative mentions

Mentions as of

12/1/2022

25 very positive mentions
39 positive mentions
12 negative mentions
1 very negative mentions

Mentions as of

12/31/2022

44 very positive mentions
49 positive mentions
18 negative mentions
9 very negative mentions

Mentions as of

1/30/2023

Current Sentiment

Recent Stories by Sentiment

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. The firm's products consist of Diabetes, Oncology, Immunology, Neuroscience, and Other therapies. The Diabetes products include Baqsimi, Basaglar, Humalog, Humulin, Jardiance, Lyumjev, Trajenta, and Trulicity. The Oncology products consist of Alimta, Cyramza, Erbitux, Retevmo, Tyvyt, and Verzenio. The Immunology products include Olumiant and Taltz. The Neuroscience products consist of Cymbalta, Emgality, Reyvow, and Zyprexa. The Other therapies include Bamlanivimab, Cialis, and Forteo. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Today's Range

Now: $340.50

$339.46

$347.80

50 Day Range

MA: $361.09

$342.10

$374.76

52 Week Range

Now: $340.50

$231.87

$384.44

Volume

2,580,160 shs

Average Volume

2,542,840 shs

Market Capitalization

$323.54 billion

P/E Ratio

51.13

Dividend Yield

1.15%

Beta

0.36

Frequently Asked Questions

What sell-side analysts currently cover shares of Eli Lilly and?: The following sell-side analysts have issued reports on Eli Lilly and in the last twelve months: Argus, Bank of America Co., Barclays PLC, Berenberg Bank, BMO Capital Markets, Citigroup Inc., Cowen Inc, Cowen Inc., Credit Suisse Group AG, Daiwa Capital Markets, Guggenheim, JPMorgan Chase & Co., Mizuho, Morgan Stanley, StockNews.com, SVB Leerink LLC, The Goldman Sachs Group, Inc., Truist Financial Co., UBS Group AG, and Wells Fargo & Company.
View the latest analyst ratings for LLY.
What is the current price target for Eli Lilly and?: 19 Wall Street analysts have set twelve-month price targets for Eli Lilly and in the last year. Their average twelve-month price target is $384.11, suggesting a possible upside of 12.8%. Morgan Stanley has the highest price target set, predicting LLY will reach $440.00 in the next twelve months. Daiwa Capital Markets has the lowest price target set, forecasting a price of $286.00 for Eli Lilly and in the next year.
View the latest price targets for LLY.
What is the current consensus analyst rating for Eli Lilly and?: Eli Lilly and currently has 2 hold ratings and 11 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe LLY will outperform the market and that investors should add to their positions of Eli Lilly and.
View the latest ratings for LLY.
What other companies compete with Eli Lilly and?: Other companies that are similar to Eli Lilly and include Merck & Co., Inc., AbbVie, Pfizer, Johnson & Johnson and Bristol-Myers Squibb. Learn More about companies similar to Eli Lilly and.
How do I contact Eli Lilly and's investor relations team?: Eli Lilly and's physical mailing address is LILLY CORPORATE CENTER, INDIANAPOLIS IN, 46285. The company's listed phone number is (317) 276-2000 and its investor relations email address is [email protected] The official website for Eli Lilly and is www.lilly.com. Learn More about contacing Eli Lilly and investor relations.

Eli Lilly and - LLY Stock Price Target and Predictions

Analyst Price Target for LLY

Current Consensus is Buy

Past Monthly Recommendations

Latest Recommendations

News Sentiment Rating

0.52 (Buy)

News Sentiment Over Time

Current Sentiment

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of Eli Lilly and?

What is the current price target for Eli Lilly and?

What is the current consensus analyst rating for Eli Lilly and?

What other companies compete with Eli Lilly and?

How do I contact Eli Lilly and's investor relations team?